Cogpex Syrup

Cogpex Syrup

Cogpex Syrup

Composition :
500 mg/ 5 ml Syrup
Flavour :
Nil
Presentation :
200 ml – 1 unit
Product Category :
Rx
Indications :
Piracetam is indicated for patients suffering from myoclonus of cortical origin, irrespective of aetiology and should be used in combination with other anti-myoclonic therapies.
Description :
Piracetam improves neuronal function and micro-circulation in brain for post stroke rehabilitation cases.
Contra-indications :
Severe renal insufficiency (CrCl <20 mL/min). Hypersensitivity to piracetam or other pyrrolidone derivatives. Hepatic impairment; cerebral hemorrhage, and those who are suffering from Huntington's chorea. Patients <16 years of age
Side-effects :
Blood and Lymphatic disorders
Not known: hemorrhagic disorder.
Immune system disorders
Not known: anaphylactoid reaction, hypersensitivity
Psychiatric disorders
Common: nervousness
Uncommon: depression
Not known: agitation, anxiety, confusion, hallucination
Nervous system disorders
Common: hyperkinesia
Uncommon: somnolence
Not known: ataxia, balance impaired, epilepsy aggravated, headache, insomnia
Ear and labyrinth disorders
Not known: vertigo
Gastrointestinal disorders
Not known: abdominal pain, abdominal pain upper, diarrhea, nausea, vomiting
Skin and subcutaneous tissue disorders
Not known: angioneurotic edema, dermatitis, pruritus, urticaria
General disorders and administration site conditions
Uncommon: asthenia
Investigations
Common: weight increased
Precautions :
Effects on platelet aggregation
Due to the effect of piracetam on platelet aggregation, caution is recommended in patients with severe hemorrhage, patients at risk of bleeding such as gastrointestinal ulcer, patients with underlying disorders of haemostasis, patients with history of haemorrhagic CVA, patients undergoing major surgery including dental surgery, and patients using anticoagulants or platelet antiaggregant drugs including low dose aspirin.
Renal insufficiency
Piracetam is eliminated via kidney and thus care should be taken in cases of renal insufficiency.
Elderly
For long-term treatment in the elderly, regular evaluation of the creatinine clearance is required to allow dosage adaptation if needed.
Discontinuation
Abrupt discontinuation of treatment should be avoided as this may induce myoclonic or generalised seizures in some myoclonic patients.
Dosage :
For children:
The standard Piracetam (Cogpex) dose is between 40-100 mg/kg of bodyweight.
For adults:
The standard Piracetam (Cogpex) dose is between 2 gm-4.8 gm two to three times in a day.
Storage conditions :
Store protected from light and moisture, at a temperature not exceeding 30°C.